1-3 of 3
Glenn Kroog
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase 2 Study of Elotuzumab (Elo) in Combination with Lenalidomide and Low-Dose Dexamethasone (Ld) in Patients (pts) with Relapsed/Refractory Multiple Myeloma (R/R MM): Updated Results

Free
Paul G. Richardson, MD, Sundar Jagannath, MD, Philippe Moreau, MD, Andrzej Jakubowiak, MD, PhD, Marc S Raab, Thierry Facon, MD, Ravi Vij, MBBS, Darrell J. White, MD, Donna Reece, Lotfi Benboubker, MD, PhD, Jeffrey A. Zonder, MD, Wei Deng, Glenn Kroog, MD, Anil K Singhal, MD, Sagar Lonial, MD
Journal: Blood
Blood (2012) 120 (21): 202.
https://doi.org/10.1182/blood.V120.21.202.202
Published: 2012
Journal Articles

Investigation of the Association Between Treatment Effects On Progression Free Survival and Overall Survival in Multiple Myeloma Using Data From Published Literature

Free
Bin Zhang, Shannon Cartier, Virginia Rosen, April Teitelbaum, Ying Zhang, Blake J Bartlett, PhD, Glenn Kroog, MD, Pralay Mukhopadhyay, Samuel Wagner, PhD, RPh
Journal: Blood
Blood (2012) 120 (21): 4241.
https://doi.org/10.1182/blood.V120.21.4241.4241
Published: 2012
Journal Articles

A Phase 2 Study of Elotuzumab in Combination with Lenalidomide and Low-Dose Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma

Free
Sagar Lonial, MD, Andrzej J Jakubowiak, MD, PhD, Sundar Jagannath, MD, Marc S Raab, MD, PhD, Thierry Facon, MD, Ravi Vij, MD, Philippe Moreau, MD, Donna E. Reece, MD, FRCPC, Darrell J. White, MD, Lotfi Benboubker, MD, PhD, Jeffrey A. Zonder, MD, Jean-Francois Rossi, MD, PhD, Claire Tsao, Teresa Parli, Glenn Kroog, MD, Anil K Singhal, Paul G. Richardson, MD
Journal: Blood
Blood (2011) 118 (21): 303.
https://doi.org/10.1182/blood.V118.21.303.303
Published: 2011